Arcutis Biotherapeutics (ARQT) Stock Price, Quote, News & History | Benzinga

Arcutis Biotherapeutics Inc (ARQT) Stock Price, Quote, News & History

ARQTNASDAQ

Trade with Public

Trade with Public

$25.61

At close: Aug 18, 5:00 PM EST

$25.61

N/A

After Hours: 4:00 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

-

Close

-

Volume / Avg.

0 / 1.69M

Day Range

- - -

52 Wk Range

15.10 - 31.77

Market Cap

$3.22B

P/E Ratio

116.41

Dividend Yield

-

Exchange

NASDAQ

RSI

41

Short Interest

10.76%

Days to Cover

10.74

Recent Arcutis Biotherapeutics, Inc. News

Crude Oil Falls Over 2%; PayPal Shares Spike Higher

Avi Kapoor

Wayfair, Qorvo, Celestica, United Parcel Service, Regeneron Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday

Avi Kapoor

Top 5 Biotech Stocks With Strong Momentum

Top 5 biotech stocks jumping into the top 10% momentum this week—ADCT, ARQT, CLLS, ENTO, HOTH—amid rapid sector rallies.

Rishabh Mishra

This Palantir Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Avi Kapoor

Arcutis Unveils Long-Term Efficacy, Safety For Zoryve Cream In Pediatric Patients With Atopic Dermatitis

Arcutis will present five posters at RAD 2025 featuring long-term safety and efficacy data for Zoryve cream in children with eczema.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

39.31M

Investing Cash Flow (TTM)

-85.98M

Financing Cash Flow (TTM)

8.26M

Free Cash Flow (TTM)

39.15M

Capital Expenditure (TTM)

-158.00K

Net Change in Cash (TTM)

-38.42M

Analyst Trends and Forecast

4

Feb

1

Mar

1

May

3

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$3.09B

PE Ratio (TTM)

116.41

PE Ratio (FWD)

58.14

PEG Ratio (TTM)

-

PS Ratio (TTM)

7.28

PB Ratio (TTM)

14.59

Earnings Yield % (TTM)

0.86%

Earnings Yield % (FWD)

1.72%

EV / EBITDA (TTM)

68.17

Price / EBITDA (TTM)

74.44

Price / Free Cash Flow (TTM)

86.31

Book Value / Share

$1.75

Company Debt

Total Debt

$108.90M

LT Debt

$101.95M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$34.12M

Debt to Equity

0.52

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

-

Close

-

Volume / Avg.

0 / 1.69M

Day Range

- - -

52 Wk Range

15.10 - 31.77

Market Cap

$3.22B

P/E Ratio

116.41

Dividend Yield

-

Exchange

NASDAQ

RSI

41

Short Interest

10.76%

Days to Cover

10.74

About

Sector

Health Care

Industry

Biotechnology

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical a...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Arcutis Biotherapeutics (ARQT) stock?

A

You can purchase shares of Arcutis Biotherapeutics (NASDAQ:ARQT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Arcutis Biotherapeutics (ARQT) competitors?

A

Other companies in Arcutis Biotherapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Arcutis Biotherapeutics (ARQT) stock?

A

Arcutis Biotherapeutics has a consensus price target of $31.00.

Q

What is the current price for Arcutis Biotherapeutics (ARQT)?

A

The stock price for Arcutis Biotherapeutics (NASDAQ: ARQT) is $25.61 last updated August 17, 2026 at 4:00 PM EDT.

Q

Does Arcutis Biotherapeutics (ARQT) pay a dividend?

A

There are no upcoming dividends for Arcutis Biotherapeutics.

Q

When is Arcutis Biotherapeutics (NASDAQ:ARQT) reporting earnings?

A

Arcutis Biotherapeutics does not have any upcoming earnings scheduled.

Q

Is Arcutis Biotherapeutics (ARQT) going to split?

A

There is no upcoming split for Arcutis Biotherapeutics.

Q

What sector and industry does Arcutis Biotherapeutics (ARQT) operate in?

A

Arcutis Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.